I recon this is why TGA approval is delayed, ie focus and application was home testing, but TGA weren’t ready to support that approach yet due to Pobnfg’s point.
As a result AT1 have pivoted their local strategy and firmed up branding distribution rights with NG in the meantime.
Just a thought.
- Forums
- ASX - By Stock
- AT1
- AT1 role in serology testing
AT1
atomo diagnostics limited
Add to My Watchlist
5.26%
!
1.8¢

AT1 role in serology testing, page-9
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.8¢ |
Change
-0.001(5.26%) |
Mkt cap ! $13.87M |
Open | High | Low | Value | Volume |
1.9¢ | 1.9¢ | 1.8¢ | $17.39K | 954.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 206302 | 1.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.9¢ | 77014 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 206302 | 0.018 |
7 | 1169208 | 0.017 |
10 | 2211478 | 0.016 |
9 | 3134905 | 0.015 |
17 | 4886432 | 0.014 |
Price($) | Vol. | No. |
---|---|---|
0.019 | 77014 | 3 |
0.020 | 333813 | 4 |
0.021 | 407868 | 3 |
0.022 | 473894 | 2 |
0.023 | 296636 | 2 |
Last trade - 14.12pm 23/07/2025 (20 minute delay) ? |
Featured News
AT1 (ASX) Chart |